Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia

D Chiavolini, J Rangel-Moreno, G Berg, K Christian… - PloS one, 2010 - journals.plos.org
Background Francisella tularensis causes severe pulmonary disease, and nasal vaccination
could be the ideal measure to effectively prevent it. Nevertheless, the efficacy of this type of …

Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain

JA Skyberg, MCF Rollins, JW Samuel… - Infection and …, 2013 - Am Soc Microbiol
Francisella tularensis is a highly infectious intracellular bacterium that causes the zoonotic
infection tularemia. While much literature exists on the host response to F. tularensis …

Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice

R De Pascalis, L Mittereder, AY Chou, NJ Kennett… - PLoS …, 2015 - journals.plos.org
In the last decade several new vaccines against Francisella tularensis, which causes
tularemia, have been characterized in animal models. Whereas many of these vaccine …

A tolC Mutant of Francisella tularensis Is Hypercytotoxic Compared to the Wild Type and Elicits Increased Proinflammatory Responses from Host Cells

GJ Platz, DAC Bublitz, P Mena, JL Benach… - Infection and …, 2010 - Am Soc Microbiol
The highly infectious bacterium Francisella tularensis is a facultative intracellular pathogen
and the causative agent of tularemia. TolC, which is an outer membrane protein involved in …

Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection

SL Kurtz, O Foreman, CM Bosio, MR Anver… - Infection and …, 2013 - Am Soc Microbiol
We employed Francisella tularensis live vaccine strain (LVS) to study mechanisms of
protective immunity against intracellular pathogens and, specifically, to understand …

Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112ΔiglB:: fljB

AL Cunningham, KM Dang, JJ Yu, MN Guentzel… - Vaccine, 2014 - Elsevier
Oral vaccination with the defined live attenuated Francisella novicida vaccine strain
U112ΔiglB has been demonstrated to induce protective immunity against pulmonary …

Identification of a live attenuated vaccine candidate for tularemia prophylaxis

M Mahawar, SM Rabadi, S Banik, SV Catlett… - PLoS …, 2013 - journals.plos.org
Francisella tularensis is the causative agent of a fatal human disease, tularemia. F.
tularensis was used in bioweapon programs in the past and is now classified as a category …

Role of antibody to lipopolysaccharide in protection against low-and high-virulence strains of Francisella tularensis

M Fulop, P Mastroeni, M Green, RW Titball - Vaccine, 2001 - Elsevier
Mice immunised with lipopolysaccharide (LPS) from Francisella tularensis were protected
against challenge with the live vaccine strain (LVS). However, when similarly immunised …

Purified Lipopolysaccharide from Francisella tularensis Live Vaccine Strain (LVS) Induces Protective Immunity against LVS Infection That Requires B Cells and …

VC Dreisbach, S Cowley, KL Elkins - Infection and immunity, 2000 - Am Soc Microbiol
Previous results have demonstrated that nonspecific protective immunity against lethal
Francisella tularensis live vaccine strain (LVS) or Listeria monocytogenes infection can be …

Humoral and cell‐mediated immunity to the intracellular pathogen Francisella tularensis

GS Kirimanjeswara, S Olmos, CS Bakshi… - Immunological …, 2008 - Wiley Online Library
Francisella tularensis can cause fatal respiratory tularemia in humans and animals and is
increasingly being isolated in the United States and several European countries. The …